Mitochondrial Medicine: Developing New Treatments for Mitochondrial Disease
4–6 May 2016
Wellcome Genome Campus, Hinxton, UK
We are pleased to announce the 2nd in our series of meetings on
mitochondrial disorders and the quest for novel effective therapies.
Mitochondrial diseases form the largest group of inherited metabolic
disorders, and the past decade has seen major advances in our
understanding of the molecular mechanisms involved. Novel therapeutic
strategies are being developed based on this new knowledge, and
preclinical studies in animal models show great promise.
This conference will bring together world leaders in the field of
translational mitochondrial medicine in an interactive programme designed
to engage and inspire a new generation of mitochondrial researchers, who
will harness this new technology to prevent and treat these devastating
The meeting attracts international participants interested in
mitochondrial diseases, working in molecular genetics, biochemistry,
pathology, and clinical medicine.
The conference will start at approximately 11:30 with registration on
Wednesday 4 May and close at approximately 13.00 on Friday 6 May
- Novel mechanisms of mitochondrial disease
- Measuring clinical progression
- Disease biomarkers
- Precision medicines
- Targeted treatment
- Current active trials
Organisers and speakers
Scientific programme committee
Patrick Chinnery University of Cambridge, UK
Marni Falk The Children’s Hospital of Philadelphia, USA
Vamsi Mootha Harvard Medical School, USA
Jan Smeitink Radboud UMC, The Netherlands
Anu Suomalainen University of Helsinki, Finland
Massimo Zeviani MRC Mitochondrial Biology Unit, Cambridge, UK
Mary Herbert University of Newcastle, UK
Saskia Koene Radboud UMC, The
Michal Minczuk MRC Mitochondrial Biology Unit, Cambridge, UK
Carlos Moraes University of Miami Miller School of
Michael Murphy MRC Mitochondrial Biology Unit,
Holger Prokisch Technische Universität
Elena Rugarli University of Cologne, Germany
Luca Scorrano University of Padova, Italy
Valeria Tiranti Foundation IRCCS-Neurological Institute
C. Besta, Italy
Douglas Turnbull University of Newcastle, UK
Alex Whitworth MRC Mitochondrial Biology Unit, Cambridge, UK
Lucy Criddle Wellcome Genome Campus, UK
How to apply
|Student||On site twin accommodation||£350.00|
|Student||On site single accommodation||£415.00|
|Academic||On site twin accommodation||£450.00|
|Academic||On site single accommodation||£515.00|
|Commercial||On site twin accommodation||£550.00|
|Commercial||On site single accommodation||£615.00|
The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
Registration deadline: Closed
Accommodation is provided for the nights of 4 and 5 May 2016. Please
note: there is limited on-site accommodation and this will be allocated
on a first-come, first-served basis. Therefore, early registration is
If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.
Contact the conference organiser if you require a letter to support a
travel visa application. Note that letters will only be provided to
Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
Please visit the following websites for further information:
UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/
Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/
A limited number of registration bursaries are available for PhD students
to attend this conference (up to 50% of the registration fee) from
Wellcome Genome Campus Scientific Conferences.
The following documents will need to be provided:
- Covering letter
- Letter from supervisor
To apply, please contact the conference organiser.
Bursary deadline: Closed
We welcome abstracts from all areas relevant to the main themes of the
meeting, for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.
Please register prior to submitting your abstract. Abstracts will not be
considered from anyone who has not registered to attend the conference.
Please follow the guidelines below when submitting your abstract.
The scientific programme committee will assess your abstract after the
deadline has passed and you will be notified whether you have been
selected for an oral or poster presentation.
Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-
portrait) of printed material. Accepted abstracts will appear in the
conference programme book and poster boards will be allocated at the
Abstract deadline: Closed
- Format & Font: Prepare your abstract in Microsoft Word in 11-point Ariel Font.
- Title: The title should be concise and be in bold, sentence case.
- Author names: The presenting author’s name must be the first name to appear on the list of authors. Underline the name of the presenting author. For each author give the forename followed by the surname.
- Affiliations: Please list the authors and affiliations directly under the title, separated by one empty line, and followed on additional lines as necessary. Indicate each author’s affiliation with a superscript numeral following the surname.
- Abstract length: should not exceed one 1.5-spaced page. The total word limit is 400 words (to include title, authors, affiliations and abstract narrative).
- Abstract narrative: must be clear and concise. Clearly describe the problem you are addressing, the results to date and any conclusions you can draw from them, so that your abstract can be evaluated by the programme committee. Avoid saying in effect ‘a solution to XYZ problem will be presented’. Please ensure that your abstract is checked for correctness of spelling and grammar in advance of submission.
- Subheadings: Please avoid the use of subheadings in the abstract narrative.
- References: A separate list of references at the end of the abstract is not necessary.
- File name: should be the same as the surname of the presenting author.
- Download a sample abstract document (Microsoft Word), which can be used for formatting purposes.